Tag: Ozempic Santa

Posted on

Elon Musk Reveals He Uses Mounjaro For Weight Loss In Christmas Post – NDTV

Elon Musk, the 53-year-old CEO of Tesla and SpaceX, recently shared a festive image of himself dressed as Santa Claus, humorously captioned “Ozempic Santa.” In the comments section of the post, he clarified that he uses Mounjaro, a drug similar to Ozempic. Mounjaro is a GLP-1 inhibitor developed to help people with diabetes regulate their blood glucose and insulin levels, which has also been effective for weight loss. The billionaire said he prefers Mounjaro over Ozempic, another popular […]
Elon Musk Reveals He Uses Mounjaro For Weight Loss In Christmas Post – NDTV

Posted on

Elon Musk's Weight Loss Transformation Divides Fans As He Admits To Using Ozempic-Like Drug

Elon Musk recently shared a playful post on X, revealing he uses Mounjaro, a weight loss drug, to achieve his thinner look.
The billionaire's post featured a photo that highlighted his incredible weight loss while spreading Christmas cheer at the same time.
Elon Musk's revelation comes after President-Elect Donald Trump addressed growing concerns about his influence, noting that the Tesla boss is "not going to be President."
Elon Musk took to X to share a playful Christmas […]
Elon Musk's Weight Loss Transformation Divides Fans As He Admits To Using Ozempic-Like Drug

Posted on

Elon Musk taking Mounjaro for weight loss? His festive 'Ozempic Santa' post … – The Economic Times

Corporate Kalesh: Top family disputes of India Inc in 2024
The world of business lost these eminent people in 2024
Fast, faster, fastest: How 2024 put more speed into your shopping
— elonmusk (@elonmusk) The tech mogul also revealed he took Mounjaro, a drug similar to Ozempic, which helps regulate blood sugar levels in type-2 diabetes patients. Musk also shared a childhood picture of himself in a similar Santa look.ALSO READ: Trump’s Christmas wish list: Annexing Canada, seizing Panama […]
Elon Musk taking Mounjaro for weight loss? His festive 'Ozempic Santa' post … – The Economic Times